Effects of methylprednisolone on lesioned and uninjured mammalian spinal neurons: Viability, ultrastructure, and network electrophysiology

Journal of Neurotrauma

Volumn 13, Issue 8, 1996, Pages 417-437

  Rosenberg, Lisa J ^a   Jordan, Rusty S ^b   Gross, Guenter W ^b   Emery, Dennis G ^c   Lucas, Jen H ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH TEXAS   (United States)

^c IOWA STATE UNIVERSITY   (United States)

Author keywords

methylprednisolone; neuronal network activity; neuronal survival; spinal cord; toxicity; trauma; ultrastructure

Indexed keywords

4 AMINOBUTYRIC ACID; METHYLPREDNISOLONE SODIUM SUCCINATE; N METHYL DEXTRO ASPARTIC ACID;

ANIMAL CELL; ARTICLE; CELL SURVIVAL; CELL ULTRASTRUCTURE; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROPHYSIOLOGY; MOUSE; NERVE CELL EXCITABILITY; NERVE CELL LESION; NERVE CELL NECROSIS; NERVE CELL NETWORK; NERVE FIBER TRANSECTION; NONHUMAN; SPINAL CORD NERVE CELL;

EID: 0029831333     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.1996.13.417     Document Type: Article

References (65)

1. ANDERSON, D.K., ANDERSON, D.K., and MEANS, E.D. (1985). Iron-induced lipid peroxidation in spinal cord: Protection with mannitol and methylprednisolone. J. Free Radical Biol. Med. 1, 59-64.
2. ANDERSON, D.K., DEMEDIUK, P., SAUNDERS, R.D., DUGAN, L.L., MEANS, E.D., and HORROCKS, L.A. (1985). Spinal cord injury and protection. Annals Emerg. Med. 14, 816-821.
3. ANDERSON, D.K., DUGAN, L.L., MEANS, E.D., and HORROCKS, L.A. (1994). Methylprednisolone and membrane properties of primary cultures of mouse spinal cord. Brain Res. 637, 119-125.
4. BALENTINE, J.D. (1978). Pathology of experimental spinal cord trauma. II. Ultrastructure of axons and myelin. Lab. Invest. 39, 254-266.
5. BANIK, N.L., HOGAN, E.L., and HSU, C.Y. (1987). The multimolecular cascade of spinal cord injury: Studies on prostanoids, calcium and proteinases. Neurochem. Pathol. 7, 57-77.
6. BLACKWELL, G.J., and FLOWER, R.J. (1983). Inhibition of phospholipase. Br. Med. Bull. 39, 260-264.
7. BORGENS, R.B., JOFFE, L.F., and COHEN, M.J. (1980). Large and persistent electrical currents enter the transected lamprey spinal cord. Proc. Natl. Acad. Sci. U.S.A. 77, 1209-1213.
8. BRACKEN, M.B., SHEPARD, M.J., COLLINS, W.F., et al. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N. Engl. J. Med. 322, 1405-1411.
9. BRACKEN, M.B., SHEPARD, M.J., COLLINS, W.F., et al. (1992). Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. J. Neurosurg. 58, 538-542.
10. +)-ATPase activity in cats following intravenous methylprednisolone. Brain Res. 219, 464-469.
11. +)-ATPase, lipid peroxidation, and alpha motor neuron function. J. Neurosurg. 56, 838-844.
12. BRAUGHLER, J.M., and HALL, E.D. (1983a). Uptake and elimination of methylprednisolone from contused cat spinal cord following intravenous injection of the sodium succinate ester. J. Neurosurg. 58, 538-542.
13. BRAUGHLER, J.M., and HALL, E.D. (1983b). Lactate and pyruvate metabolism in injured cat spinal cord before and after a single large dose of methylprednisolone. J. Neurosurg. 59, 256-261.
14. BRAUGHLER, J.M., and HALL, E.D. (1984). Effects of multidose methylprednisolone sodium succinate administration on injured cat spinal cord neurofilament degradation and energy metabolism. J. Neurosurg. 61, 290-295.
15. BRESNAHAN, J.C. (1978). An electron microscopic analysis of axonal alterations following blunt contusion of the spinal cord of the rhesus monkey (Macaca mulatta). J. Neurol. Sci. 37, 59-82.
16. BRESNAHAN, J.C., KING, J.S., MARTIN, G.F., and YASHON, D. (1976). A neuroanatomical analysis of spinal cord injury in the rhesus monkey (Macaca mulatta). J. Neurological Sci. 28, 521-542.
17. CERILLI, J., and MILLER, J.A. (1972). The effect of massive pulse steroid therapy on the water content of the rat brain. Transplantation 14, 403-405.
18. DEMEDIUK, P., and FADEN, A.I. (1988). Arachidonic acid metabolites and membrane lipid changes in central nervous system injury, in: Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injury. D.G. Stein and B.A. Sabels (eds), Plenum, NY, pp. 23-42.
19. DEMOPOULOS, H.B., FLAMM, E.S., SELIGMAN, M.L., PIETRONIGRO, D.D., TOMASULA, J., and DECRESCITO, V. (1982). Further studies on free radical pathology in the major nervous system disorders: Effect of very high doses of methylprednisolone on the functional outcome, morphology and chemistry of experimental spinal cord impact injury. Can. J. Physiol. Pharmacol. 60, 1416-1424.
20. DERENDORF, H., MOLLMANN, H., ROHDEWALD, P., REHDER, J., and SCHMIDT, E.W. (1985). Kinetics of methylprednisolone and its hemisuccinate ester. Clin. Pharm. Ther. 37, 502-507.
21. EMERY, D.G., LUCAS, J.H., and GROSS, G.W. (1987). The sequence of ultrastructural changes in cultured neurons after dendrite transection. Exp. Brain Res. 67, 41-51.
22. EMERY, D.G., LUCAS, J.H., and GROSS, G.W. (1991). Contributions of sodium and chloride to ultrastructural damage after dendrotomy. Exp. Brain Res. 86, 60-72.
23. EMERY, D.G., ROSENBERG, L.J., and LUCAS. J.H. (1995). Reduction of NaCl ameliorates ultrastructural damage to dendrotomized mammalian spinal neurons. Soc. Neurosci. Abstr. 21, 2118.
24. FOROUTAN, A., BEHBEHANI, M.M., and ANDERSON, D.K. (1996). Effects of methylprednisolone on the GABA- and glutamate-induced currents: Relevance to glucoconicoid-induced neurotoxicity and brain aging. Steroids 61, 354-366.
25. GROSS, G.W. (1979). Simultaneous single unit recording in vitro with a photoetched laser deinsulated gold multimicroelectrode surface. IEEE Trans. Biomend. Eng. 26, 273-279.
26. GROSS, G.W., and HIGGINS, M.L. (1987). Cytoplasmic damage gradients in dendrites after transection lesions. Exp. Brain Res. 67, 52-60.
27. GROSS, G.W., LUCAS, J.H., and HIGGINS, M.L. (1983). Laser microbeam surgery: Ultrastructural changes associated with neunte transection in culture. J. Neurosci. 3, 1979-1993.
28. GROSS, G.W., WEN, W., and LIN, J. (1985). Transparent indium-tin oxide patterns for extracellular multisite recording in neuronal cultures. J. Neurosci. Methods 15, 243-252.
29. HALL, E.D. (1982). Glucocorticoid effects on central nervous excitability and synaptic transmission. Int. Rev. Neurobiol. 23, 165-195.
30. HALL, E.D. (1991). Inhibition of lipid peroxidation in CNS trauma. J. Neurotrauma 8, S31-S41.
31. HALL, E.D. (1993). Neuroprotective actions of glucocorticoid and nonglucocorticoid steroids in acute neuronal injury. Cell. Mol. Neurobiol. 13, 415-432.
32. HALL, E.D., and BRAUGHLER, J.M. (1981). Acute effects of intravenous glucocorticoid pretreatment on the in vitro peroxidation of cat spinal cord tissue. Exp. Neural. 73, 321-324.
33. +)-ATPase activity: Dose-response analysis during the first hour after contusion injury in the cat. J. Neurosurg. 57, 247-253.
34. HALL, E.D., and WOLF, D.L. (1986). A pharmacological analysis of the pathophysiological mechanisms of post-traumatic spinal cord ischemia. J. Neurosurg. 64, 951-961.
35. HALL, E.D., WOLF, D.L., and BRAUGHLER, J.M. (1984). Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia: Dose-response and time-action analysis. J. Neurosurg. 61, 124-130.
36. HALL, E.D., BRAUGHLER, J.M., and MCCALL, J.M. (1988). New pharmacological treatment of acute spinal cord trauma. J. Neurotrauma 5, 81-89.
37. HAUGHEY, D.B., and JUSKO, W.J. (1988). Analysis of methylprednisolone, methylprednisone and corticosterone for assessment of methylprednisolone disposition in the rat. J. Chromatogr. 430, 241-248.
38. HOLTZ, A., NYSTROM, B., and GERDIN, B. (1990). Effect of methylprednisolone on motor function and spinal cord flow after spinal cord compression in rats. Acta Neurolog. Scand. 82, 68-73.
39. IWAI, A., MONAFO, W.W., and ELIASSON, S.G. (1993). Methylprednisolone treatment of experimental spinal cord injury. Paraplegia 31, 417-429.
40. LIU, D., and MCADOO, DJ. (1993). Methylprednisolone reduces excitatory amino acid release following experimental spinal cord injury. Brain Res. 609, 293-297.
41. LUCAS, J.H. (1987). Proximal segment retraction increases the probability of nerve cell survival after dendrite transection. Brain Res. 425, 384-387.
42. LUCAS, J.H., GROSS, G.W., EMERY, D.G., and GARDNER, C.R. (1985). Neuronal survival or death after dendrite transection close to the perikaryon: Correlation with electrophysiologic, morphologic and ultrastructural changes. J. Neurotrauma (formerly Central Nervous System Trauma) 2, 231-255.
43. LUCAS, J.H., CZISNY, L.E., and GROSS, G.W. (1986). Adhesion of cultured mammalian central nervous system neurons to flame-modified hydrophobic surfaces. In Vitro 22, 37-43.
44. LUCAS, J.H., EMERY, D.G., HIGGINS, M.L., and GROSS, G.W. (1990). Neuronal survival and dynamics of ultrastructural damage after dendrotomy in low calcium. J. Neurotrauma 7, 169-192.
45. LUCAS, J.H., and ROSENBERG-SCHAFFER, L.J. (1994). Reduction of NaCl increases survival of mammalian spinal cord neurons after neunte transection injury. Soc. Neurosci. Abst. 20, 844.
46. LUCAS, J.H., EMERY, D.G., and GROSS, G.W. (1995). Tissue culture studies of neuronal responses to physical lesions of the plasma membrane: Environmental influences and experimental interventions, in: Membrane-Linked Diseases Vol. 4. S.T. Ohnishi and T. Ohnishi (eds), Taylor and Francis, NY, pp. 353-373.
47. MEIRI, H., SPIRA, M.E., and PARNAS, I. (1981). Membrane conductance and action potentials of a regenerating axonal tip. Science 211, 709-712.
48. 2 as a further possible mechanisms of some actions of steroidal anti-inflammatory drugs. Pharm. Res. Commun. 12, 817-827.
49. PETERS, A., PALAY, S.L., and WEBSTER, H. deF. (1976). The Fine Structure of the Nervous system. Saunders, Philadelphia, p. 10.
50. PHILLIPS, H.J. (1973). A three-dye test for cell viability, in: Tissue Culture, Methods and Applications. P.F. Kruse, Jr. and M.J. Patterson, Jr. (eds), Academic Press, NY, pp. 406-408.
51. RANSOM, B.R., NEALE, E., HENKHARY, M., BULLOCK, P.N., and NELSON, P.G. (1977). Mouse spinal cord in cell culture. I. Morphological and intrinsic electrophysiologic properties. J. Neurophysiol. 40, 1132-1150.
52. ROSENBERG, L.J., EMERY, D.G., and LUCAS, J.H. (1995). Reduction of extracellular Na+ increases survival of spinal cord neurons subjected to dendrotomy. Soc. Neurosci. Abst. 21, 2118.
53. ROSENBERG-SCHAFFER, L.J., and LUCAS, J.H. (1993). An in vitro study of the effects of methylprednisolone on lesioned and uninjured mammalian spinal neurons. Brain Res. 605, 327-331.
54. SAUNDERS, R.D., DUGAN, L.L., DEMEDIUK, P., MEANS, E.D., HORROCKS, L.A., and ANDERSON, D.K. (1987). Effects of methylprednisolone and the combination of alpha-tocopherol and selenium on arachidonic acid metabolism and lipid peroxidation in traumatized spinal cord tissue. J. Neurochem. 49, 24-31.
55. SELIGMAN, M.L., MITAMURA, J., SHERA, N., and DEMOPOULOS, H.B. (1979). Corticosteroid (methylprednisolone) modulation of photoperoxidation by ultraviolet light in liposomes. Photochem. Photobiol. 29, 549-558.
56. SHAW, J.A., and WEBER, D.J. (1985). High-performance liquid Chromatographic assay for methylprednisolone and its soluble prodrug esters in dog plasma. J. Chromatogr. 344, 41-49.
57. STOKES, B.T., FOX, P., and HOLLINDEN, G. (1983). Extracellular calcium activity in the injured spinal cord. Exp. Neurol. 80, 561-572.
58. STUBBS, S.S., and MORRELL, R.M. (1973). Intravenous methylprednisolone sodium succinate: Adverse reactions reported in association with immunosuppressive therapy. Transplant Proc. 5, 1145-1146.
59. SUCHMAN, A.L., CONDEMI, J.J., and LEDDY, J.P. (1983). Seizure after pulse therapy with methylprednisolone. Arthritis Rheum. 26, 117.
60. 2 from inflammatory sites in rats. Proc. Natl. Acad. Sci. U.S.A. 87, 2395-2399.
61. 2 activation and neuronal injury. Ann. N.Y. Acad. Sci. 679, 110-120.
62. YOUNG, W., and FLAMM, E.S. (1982). Effect of high dose corticosteroid therapy on blood flow, evoked potentials and extracellular calcium in experimental spinal cord injury. J. Neurosurg. 57, 557-673.
63. YOUNG, W., and KOREH, I. (1986). Potassium and calcium changes in injured spinal cords. Brain Res. 253, 189-253.
64. YOUNG, W., YEN, V., and BLIGHT, A. (1982). Extracellular calcium ionic activity in experimental cord contusion. Brain Res. 253, 105-113.
65. YOUNG, W., DECRESCITO, V., FLAMM, E.S., BLIGHT, A.R., and GRUNER, J.A. (1988). Pharmacological therapy of acute spinal cord injury: Studies of high-dose methyl-prednisolone and naloxone. Clin. Neurosurg. 34, 675-697.